A new fluorescent technology called homogeneous time-resolved fluorescence (HTRF) is sensitive, homogeneous, and quite tolerant to extremes in reaction conditions. These characteristics make this technique an attractive candidate for use in high throughput screens. The assay system uses a pair of fluorescent compounds to label biomolecules. The long-lived nature of the fluorescence of one of them, europium cryptate, facilitates the homogeneous nature of the assay. Furthermore, the introduction of a time delay in reading the signal eliminates the principal difficulty in applying fluorescence to screening formats, that of endogenous fluorescence of samples tested (especially natural products). This technique is robust and sensitive, and we report here its utility in a high throughput screening format.
References
1.
Udenfriend, S., Gerber, L.D., Brink, L., Spector, S. (1985). Scintillation proximity radioimmunoassay utilizing 1251-labeled ligands. Proc. Natl. Acad. Sci. USA82:8672.
2.
Kolb, A., Neumann, K., Mathis, G. (1996). New developments in HTS technology. Pharm. Manuf. Int. p. 31.
3.
Mathis, G. (1993). Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. Clin. Chem.39:1953.
4.
Mathis, G. (1995). Probing molecular interactions with homogeneous techniques based on rare earth cryptates and fluorescence energy transfer. Clin. Chem.41:1391.
5.
Alpha, B., Lehn, J-M., Mathis, G. (1987). Energy transfer luminescence of europium (III) and terbium (III) cryptates of macrobicyclic polypyridine ligands. Angew. Chem. Int. Ed. Engl.26:266.
6.
Mathis, G., Preaudat, M., Trinquet, E. (1994). Homogeneous EGF receptor binding assay using rare earth cryptates, amplification by non radiative energy transfer and time resolved fluorescence (Abstract). CHI Conference on High-Throughput Screening for Drug Development. Philadelphia. Cambridge Healthtech Institute, Waltham, MA.
7.
Mathis, G., Preaudat, M., Trinquet, E., Pernelle, C., Trouillas, M. (1994). A new homogeneous method using rare earth cryptates and amplification by energy transfer for characterization of the Fos and Jun leucine zipper peptides dimerization (Abstract). CHI Conference on High-Throughput Screening for Drug Development. Philadelphia. Cambridge Healthtech Institute, Waltham, MA.
8.
Luckow, V., Summers, M. (1988). High level expression of nonfused foreign genes withAutographa californica nuclear polyhedrosis virus expression vectors. Virology170:31.
9.
Yamanaka, G., Dilanni, C.L., O'Boyle, D.R. II, Stevens, J., Weinheimer, S.P., Deckman, I.C., Matusick-Kumar, L., Colonno, R.J. (1995). Stimulation of the herpes simplex virus type I protease by antichaeotrophic salts. J. Biol. Chem.270:30168.
